Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Morris

Showing results (231-240 of 435) with videos related to

Pageof 44
Sort By:
Anticancer Research|April 4, 2008
A new peritoneal carcinomatosis model in cyclosporine immunosuppressed ratsJaved Akhter, Peng Yao, Loreena A Johnson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 6, 2020
Outcomes in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for maximal volume (PCI 39) appendiceal tumoursAmit Sarkar, Joshua Lansom, Anindita Dey, et al.
American Journal of Cancer Research|July 12, 2021
Monepantel antitumor activity is mediated through inhibition of major cell cycle and tumor growth signaling pathwaysFarnaz Bahrami, Ahmed H Mekkawy, Samina Badar, et al.
International Journal of Surgery (London, England)|June 30, 2016
Impacts of peritoneal cancer index on the survival outcomes of patients with colorectal peritoneal carcinomatosisYeqian Huang, Nayef A Alzahrani, Terence C Chua, et al.
ANZ Journal of Surgery|December 28, 2020
Distinguishing peritoneal tuberculosis from peritoneal carcinomatosis: a challengeAbbas El-Hajj Hussein, Joshua D Lansom, Nayef A Alzahrani, et al.
Annals of Surgical Oncology|October 18, 2014
Is yttrium-90 radioembolization a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases? A large single-center experience of 302 patientsAkshat Saxena, Baerbel Meteling, Jada Kapoor, et al.
Annals of Surgical Oncology|October 31, 2009
Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment optionAkshat Saxena, Lourens Bester, Terence C Chua, et al.
International Journal of Cancer|January 30, 2015
Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancerSamar Masoumi-Moghaddam, Afshin Amini, Ai-Qun Wei, et al.
Annals of Surgical Oncology|April 15, 2011
Surgical cytoreduction and survival in appendiceal cancer peritoneal carcinomatosis: an evaluation of 46 consecutive patientsTerence C Chua, Ihssan Al-Alem, Akshat Saxena, et al.
American Journal of Cancer Research|June 24, 2015
Sprouty 1 predicts prognosis in human epithelial ovarian cancerSamar Masoumi-Moghaddam, Afshin Amini, Ai-Qun Wei, et al.
Pageof 44

Showing results (231-240 of 435) with videos related to

Sort By:
Pageof 44
Anticancer Research|April 4, 2008
A new peritoneal carcinomatosis model in cyclosporine immunosuppressed ratsJaved Akhter, Peng Yao, Loreena A Johnson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 6, 2020
Outcomes in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for maximal volume (PCI 39) appendiceal tumoursAmit Sarkar, Joshua Lansom, Anindita Dey, et al.
American Journal of Cancer Research|July 12, 2021
Monepantel antitumor activity is mediated through inhibition of major cell cycle and tumor growth signaling pathwaysFarnaz Bahrami, Ahmed H Mekkawy, Samina Badar, et al.
International Journal of Surgery (London, England)|June 30, 2016
Impacts of peritoneal cancer index on the survival outcomes of patients with colorectal peritoneal carcinomatosisYeqian Huang, Nayef A Alzahrani, Terence C Chua, et al.
ANZ Journal of Surgery|December 28, 2020
Distinguishing peritoneal tuberculosis from peritoneal carcinomatosis: a challengeAbbas El-Hajj Hussein, Joshua D Lansom, Nayef A Alzahrani, et al.
Annals of Surgical Oncology|October 18, 2014
Is yttrium-90 radioembolization a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases? A large single-center experience of 302 patientsAkshat Saxena, Baerbel Meteling, Jada Kapoor, et al.
Annals of Surgical Oncology|October 31, 2009
Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment optionAkshat Saxena, Lourens Bester, Terence C Chua, et al.
International Journal of Cancer|January 30, 2015
Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancerSamar Masoumi-Moghaddam, Afshin Amini, Ai-Qun Wei, et al.
Annals of Surgical Oncology|April 15, 2011
Surgical cytoreduction and survival in appendiceal cancer peritoneal carcinomatosis: an evaluation of 46 consecutive patientsTerence C Chua, Ihssan Al-Alem, Akshat Saxena, et al.
American Journal of Cancer Research|June 24, 2015
Sprouty 1 predicts prognosis in human epithelial ovarian cancerSamar Masoumi-Moghaddam, Afshin Amini, Ai-Qun Wei, et al.
Pageof 44